CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Guggenheim analyst Seamus Fernandez downgraded GSK (GSK) to Neutral from Buy without a price target following the Q3 report. While the company’s guidance appears achievable and it is a ...

I do a lot of my listening when travelling, so a dedicated hi-res music player that holds all my CD-quality and hi-res music files is essential. A good music player should have a large enough storage ...

Pfizer said Tuesday that its shot’s market share climbed, noting its availability as a maternal vaccination and, most recently, in certain adults 18 years or older who are at high risk. During a ...

IDE275 (GSK959) is a potential first-in-class small molecule inhibitor of Werner Helicase that was discovered by IDEAYA in collaboration with GSK. In preclinical studies, IDE275 has demonstrated ...

IDE275 (GSK959) has demonstrated robust and selective synthetic lethality preclinically in the high microsatellite instability ... medical conference with GSK. The robust preclinical efficacy ...

Ideaya and GSK found in preclinical studies that IDE275 demonstrated robust and selective synthetic lethality in the MSI-high biomarker setting in mouse models and patient-derived xenografts. "The ...

The Commonwealth is supporting this expansion with a $21 million investment, which will create at least 200 new, high-paying jobs. This is the largest Commonwealth-supported economic development ...

THIS IS FOR GSK, THE LARGEST INVESTMENT IN MANUFACTURING ... IT WILL ALSO ADD 200 HIGH PAYING JOBS. INVESTING IN PREVENTION IS WHAT WE KNOW IS THE BEST INVESTMENT THAT WE CAN MAKE.